Improve Cancer Care.com by Q Synthesis LLC
  • Home
  • About
  • Education
  • Clinical Pathways
  • Tools & Resources
  • Discuss
Discuss, Share, and Engage

Advances in HER2-positive and HER2-low Breast Cancer

6/5/2020

0 Comments

 
This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals gain a deeper scientific understanding of recent advances in the diagnosis and management of HER2-positive and HER2-low breast cancer.
To claim CME credit for this course, please register at https://store.ascp.org/productlisting/productdetail?productId=123811419&_ga=2.269259641.929308495.1598834085-509862140.1542376895

Supported by an independent educational grant from Daiichi Sankyo, Inc.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA is President of Q Synthesis LLC.
ImproveCancerCare.com
Q Synthesis LLC
  • Home
  • About
  • Education
  • Clinical Pathways
  • Tools & Resources
  • Discuss